Erik L. Ridley and Philip Ward[email protected]AIRadNet broadens AI focus with acquisitions of Aidence, QuantibImaging services provider RadNet has acquired Dutch artificial intelligence (AI) software developers Aidence and Quantib in deals that the company hopes will enable wide-scale screening programs for lung and prostate cancer.January 23, 2022Page 1 of 1Top StoriesMolecular ImagingPSMA PET-guided radiotherapy shows promiseA trial demonstrated that radiotherapy informed by PSMA-PET led to improved outcomes in prostate cancer patients.Practice ManagementContrast media-reduction strategies could curb emissions up to 53%Practice ManagementDoes CMS 2026 proposed rule enforce efficiency at a cost to practices?Womens ImagingMissed previous mammography screening linked to worse disease outcomesSponsor ContentDigital Innovations Shaping the Future of Radiology